Liver Transplantation Plus Chemotherapy Improves 5-Year OS Rate in Patients With CRC Liver Metastases
The addition of liver transplantation to chemotherapy led to a 5-year overall survival (OS) rate of 73% vs 9% with chemotherapy alone in patients with definitively unresectable colorectal liver metastases, meeting the primary end point of the TRANSMET …